Anonymous survey with optional confidential interviews will document how practitioners facilitate MDMA-assisted couples therapyFindings to inform ...

How much should psychedelics researchers disclose about their personal use of psilocybin, ketamine, and other drugs?

This Collection supports and amplifies research related to SDG 3 and SDG 10. Psychedelic research has experienced a renaissance internationally over the past few decades with a renewed attention to ...

Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with Switzerland already treating patients and the Czech Republic opening tightly ...

Unbound Medicine and Johns Hopkins Medicine today announced a significant expansion of the Johns Hopkins Psychiatry POC-IT Guide, a leading digital resource for clinicians and trainees worldwide. The ...

DENVER--(BUSINESS WIRE)--Unlimited Sciences, Colorado’s leading psychedelic research nonprofit, debuts the first-of-its-kind Psychedelic Info Line, providing data-driven education and informed ...

Healing Hearts, Changing Minds (HHCM) today announced the seven awardees of Walking Each Other Home: A Fund to Promote ...

Emory University is poised to expand its research on how MDMA, a psychedelic drug commonly known as ecstasy, could help patients with PTSD when coupled with a proven form of psychotherapy. The ...

The Center for Psychedelic Research is recreating real life scenarios to better understand how drugs and alcohol affect the ...

Rick Doblin had come to believe that psychedelic experiences are the "common core" of all religions, and he wanted to test this thesis. In February 1984, the 31-year-old college student living off a ...